The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the organization’s 2018-2019 officers during its annual meeting held in June in Philadelphia.
Satoshi Minoshima, MD, PhD, professor and chair of the department of radiology and imaging sciences at the University of Utah in Salt Lake City, has become SNMMI’s new president. Dr. Minoshima is renowned for his research concerning neurodegenerative diseases and other brain disorders using innovative imaging technology. His contributions to the field include discovery of the posterior cingulate abnormality in Alzheimer’s disease and his invention and worldwide dissemination of diagnostic statistical mapping technology for molecular brain imaging.
Dr. Minoshima has served as president of the SNMMI Brain Imaging Council. His recognitions from the SNMMI include the Tetalman Memorial Award and the Kuhl-Lassen Award, both of which he received in 2006.
Vasken Dilsizian, MD, professor of radiology and medicine at the University of Maryland School of Medicine in Baltimore and chief of the division of nuclear medicine at the University of Maryland Medical center, has been named president-elect. He served as president of the Cardiovascular Council of the SNMMI in 2013-2014 and was awarded the 2014 Hermann Blumgart Award for his contributions to the science of nuclear cardiology.
Alan Packard, PhD, associate professor of radiology at Harvard Medical School and director of radiopharmaceutical research at Boston Children’s Hospital, has been named vice-president elect. At Boston Children’s Hospital, Dr. Packard is engaged in the development of radiolabeled proteins for cancer imaging and therapy and 18F-labeled small molecules for myocardial perfusion imaging. His laboratory is also developing antibodies labeled with therapeutic radionuclides that can be used to treat small metastatic lesions before they become problematic.Back To Top
SNMMI elects new officers at its annual meeting. Appl Radiol.